Philogen S.p.A.
Developing innovative biopharmaceuticals targeting angiogenesis
- B2B
About Philogen S.p.A.
Swiss-Italian biotech company focusing on developing innovative biopharmaceuticals for angiogenesis-related disorders like cancer and rheumatoid arthritis, with a diverse revenue stream
Key facts
- Industry
- Pharmaceutical Manufacturing
- Company size
- 51–250 employees
- Headquarters
- Sovicille, Toscana, Italy
- Founded
- 1996
- Revenue
- $19M – $150MTamtam estimate
- Website
- philogen.com
- linkedin.com/company/philogen
Philogen S.p.A. at a glance
Philogen S.p.A. is a B2B company in the Pharmaceutical Manufacturing industry, headquartered in Sovicille, Toscana, Italy.
Philogen S.p.A. was founded in 1996.
Philogen S.p.A. has 51–250 employees.
Philogen S.p.A.'s revenue is $19M – $150M (Tamtam estimate).
Selling to companies like Philogen S.p.A.?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies